Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal

BACKGROUND: Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against Plasmodium falciparum in highly endemic areas. Ho...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ranjitkar, Samir, Schousboe, Mette L, Thomsen, Thomas Thyge, Adhikari, Madhav, Kapel, Christian MO, Bygbjerg, Ib C, Alifrangis, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080351/
https://ncbi.nlm.nih.gov/pubmed/21457533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-75
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky